Concomitant administration of morphine and an N-methyl-D-aspartate receptor antagonist profoundly reduces inflammatory evoked spinal c-fos expression

Anesthesiology

Volumn 85, Issue 1, 1996, Pages 150-160

  Honoré, Prisca ^a   Chapman, Victoria ^b   Buritova, Jaroslava ^a   Besson, Jean Marie ^a  

^a INSERM   (France)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Analgesics, opioid: morphine; Animals: rat; Antagonists: N methyl D aspartate; Expression, c Fos: carrageenin induced; Pharmacology: glycine site; Spinal cord: antinociception; potentiation

Indexed keywords

3 AMINO 1 HYDROXY 2 PYRROLIDINONE; CARRAGEENAN; GLYCINE; MORPHINE; MU OPIATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MIXTURE; EDEMA; INFLAMMATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NOCICEPTION; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; RAT; SPINAL CORD; SUBCUTANEOUS DRUG ADMINISTRATION;

ANALGESICS, OPIOID; ANIMALS; BODY TEMPERATURE; CARRAGEENAN; GENE EXPRESSION; GENES, FOS; INFLAMMATION; MALE; MORPHINE; PYRROLIDINONES; RABBITS; RATS; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, OPIOID, MU; SPINAL CORD;

EID: 0030017947     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199607000-00021     Document Type: Article

References (58)

1. Dickenson AH: NMDA receptor antagonists as analgesics, Progress in Pain Research and Management. Edited by Fields HL, Liebeskind JC. Seattle, IASP, 1994, pp 173-87
2. Mendell LM: Physiological properties of unmyelinated fibre projection to the spinal cord. Exp Neurol 1966; 16:316-32
3. Davies SN, Lodge D: Evidence for involvement of N-methyl-D-aspartate receptors in "wind up" of class 2 neurones in the dorsal horn of the rat. Brain Res 1987; 424:402-6
4. Dickenson AH, Sullivan AF: Evidence for a role of the NMDA receptor in the frequency dependent potentiation of deep dorsal horn neurones following C-fibre stimulation. Neuropharmacology 1987; 26:1235-8
5. Dickenson AH, Aydar E: Antagonism at the glycine site on the NMDA receptor reduces spinal nociception in the rat. Neurosci Lett 1991; 121:263-6
6. Haley JE, Sullivan AF, Dickenson AH: Evidence for the N-methyl-D-aspartate receptor involvement in prolonged chemical nociception in the rat. Brain Res 1990; 518:218-26
7. Coderre TJ, Melzack R: The contribution of excitatory amino acids to central sensitization and persistent nociception after formalin-induced tissue injury. J Neurosci 1992; 12:3665-70
8. Yamamoto T, Yaksh TL: Comparison of the antinociceptive effects of pre- and post-treatment with morphine and MK-801, an NMDA antagonist, on the formalin test in the rat. ANESTHESIOLOGY 1992; 77:757-63
9. Millan MJ, Seguin L: (+)-HA966, a partial agonist at the glycine site coupled to NMDA receptors, blocks formalin-induced pain in mice Eur J Pharmacol 1993; 238:445-7
10. Hunter JC, Singh L: Role of excitatory amino acid receptors in the mediation of the nociceptive responses to formalin in the rat. Neurosci Lett 1994; 174:217-21
11. Ren K, Williams GM, Hylden JKL, Ruda MA, Dubner R: The intrathecal administration of excitatory amino acid receptor antagonists selectively attenuated carrageenin-induced behavioral hyperalgesia in rats. Eur J Pharmacol 1992; 219:235-43
12. Yamamoto T, Shimoyama N, Mizuguchi T. The effects of morphine, MK-801, an NMDA antagonist, and CP-96,345, an NK1 antagonist, on the hyperesthesia evoked by carrageenan injection in the rat paw. ANESTHESIOLOGY 1993; 78:124-33
13. Eisenberg E, LaCross S, Strassman AM: The effects of clinically tested NMDA receptor antagonist memantine on carrageenan-induced thermal hyperalgesia in rats. Eur J Pharmacol 1994; 255:123-9
14. Elliott KJ, Brodsky M, Hynansky AD, Foley KM, Inturrisi CE: Dextromethorphan suppresses both formalin-induced nociceptive behavior and the formalin-induced increase in spinal cord c-fos mRNA. Pain 1995; 61:401-9
15. Chapman V, Honoré P, Buritova J, Besson J-M: The contribution of NMDA receptor activation to spinal c-fos expression in a model of inflammatory pain. Br J Pharmacol 1995; 116:1628-34
16. Tölle TR, Castro-Lopes JM, Zieglgänsberger W: C-fos induction in the spinal cord following noxious stimulation: Prevention by opiates but not by NMDA antagonists, Proceedings of the VIth world congress on pain. Edited by Bond MR, Charlton JE, Woolf CJ. Amsterdam, Elsevier, 1991, pp 299-305
17. McQuay H, Dickenson AH: Implication of central nervous system plasticity for pain management. Anaesthesia 1990; 45:101-2
18. Woolf CJ, Thompson SWN: The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation: Implications for the treatment of post-injury pain hypersensitivity states. Pain 1991; 44:293-9
19. Dubner R, Ruda MA: Activity-dependent neuronal plasticity following tissue injury and inflammation. Trends Neurosci 1992; 15:96-103
20. Backonja M, Arndt G, Gombar KA, CheckB, Zimmermann M: Response of chronic neuropathic pain syndromes to ketamine: A preliminary study. Pain 1994; 59:51-7
21. Eide PK, Jorum E, Stubhaug A, Bremnes J, Breivik H: Relief of post-herpetic neuralgia with the N-methyl-D-aspartatic acid receptor antagonist ketamine. A double-blind, cross-over comparison with morphine and placebo. Pain 1994; 58:347-54
22. Price DD, Mao J, Frenk H, Mayer DJ: The N-methyl-D-aspartate receptor antagonist dextrometorphan selectively reduces temporal summation of second pain in man. Pain 1994; 59:165-74
23. Chapman V, Haley JE, Dickenson AH: Electrophysiologic analysis of preemptive effects of spinal opioids on N-methyl-D-aspartate receptor-mediated events. ANESTHESIOLOGY 1994; 81:1429-35
24. Chapman V, Dickenson AH: The combination of NMDA antagonism and morphine produces profound antinociception in the rat dorsal horn Brain Res 1992; 573:321-3
25. Yamamoto T, Yaksh TL: Studies on the spinal interaction of morphine and the NMDA antagonist MK-801 on the hyperesthesia observed in a rat model of sciatic mononeuropathy. Neurosci Lett 1992; 135:67-70
26. Kest B, Marek P, Liebeskind JC: The specific N-methyl-D-aspartate (NMDA) receptor antagonist MK-801 blocks U-50, 488, but not morphine antonociception. Brain Res 1992; 589:139-42
27. Kemp JA, Leeson PD: The glycine site of NMDA receptor-five years on. Trends Pharmacol 1993; 14:20-5
28. Kayser V, Guilbaud G: Local and remote modifications of nociceptive sensitivity during carrageenin-induced inflammation in the rat. Pain 1987; 28:99-107
29. Hargreaves K, Dubner R, Brown F, Flores C, Joris J: A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988; 32:77-88
30. Iadarola MJ, Brady LS, Draisci G, Dubner R: Enhancement of dynorphin gene expression in spinal cord following experimental inflammation: Stimulus specificity, behavioral parameters and opioid receptor binding Pain 1988; 35:313-26
31. Joris J, Costello A, Dubner R, Hargreaves K: Opiates supress carrageenan-induced edema and hyperthermia at doses that inhibit hyperalgesia. Pain 1990; 43:95-103
32. Draisci G, Iadarola MJ: Temporal analysis of increases in c-fos, preprodynorphin and preproenkephalin mRNAs in rat spinal cord. Mol Brain Res 1989; 6:31-7
33. Honoré P, Buritova J, Besson J-M: Carrageenin-evoked c-Fos expression in rat lumbar spinal cord: The effects of indomethacin. Eur J Pharmacol 1995; 272:249-59
34. Nozaki K, Moskowitz MA, Boccalini P: CP-93, 129, sumatriptan, dihydroergotamine block c-fos expression within rat trigeminal nucleus caudalis caused by chemical stimulation of the meninges. Br J Pharmacol 1992; 106:409-15
35. Morgan JI, Curran T: Stimulus-transcription coupling in the nervous system: Involvement of the inducible proto-oncogenes fos and jun. Annu Rev Neurosci 1991; 14:421-51
36. Morgan JI, Curran T: Immediate-early genes: Ten years on. Trends Neurosci 1995; 18:66-7
37. Hunt SP, Pini A, Evan G: Induction of c-fos-like protein in spinal cord neurons following sensory stimulation. Nature 1987; 328:632-4
38. Zieglgänsberger W, Tölle TR: The pharmacology of pain signalling. Curr Opin Neurobiol 1993; 3:611-8
39. Abbadie C, Honoré P, Fournié-Zaluski MC, Roques BP, Besson J-M: Effects of opioids and non-opioids on c-Fos immunoreactivity induced in rat lumbar spinal cord neurons by noxious heat stimulation. Eur J Pharmacol 1994; 258:215-27
40. Abbadie C, Besson J-M: c-fos Expression in rat lumbar spinal cord during the development of adjuvant-induced arthritis. Neuroscience 1992; 48:985-93
41. Presley RW, Menétrey D, Levine JD, Basbaum AI: Systemic morphine suppresses noxious stimulus-evoked Fos protein-like immunoreactivity in the rat spinal cord. J Neurosci 1990; 10:323-35
42. Jasmin L, Wang H, Tarcy-Hornoch K, Levine JD, Basbaum AI: Differential effects of morphine on noxious stimulus-evoked Fos-like immunoreactivity in subpopulation of spinoparabrachial neurons. J Neurosci 1994; 14:7252-60
43. Chapman V, Honoré P, Buritova J, Besson J-M: Cholecystokinin B receptor antagonism enhances the ability of a low dose of morphine to reduce c-Fos expression in the spinal cord of the rat. Neuroscience 1995; 67:731-9
44. Honoré P, Chapman V, Buritova J, Besson J-M: Suppra-additive Effects of Systemic Medetomidine and Morphine as Revealed by Spinal c-Fos Expression Induced by Carrageenin Inflammation in the Rat (abstract). Oxford, Brain Research Association, 1995
45. Zimmermann M: Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983; 16:109-10
46. Hsu S, Raine L, Fanger H: Use of avidin-biotin-peroxydase complex (ABC) in immunoperoxydase techniques: A comparison between ABC and unlabelled antibody (PAP) procedures. J Histochem Cytochem 1981; 29:577-80
47. Molander C, Xu Q, Grant G: The cytoarchitectonic organization of the spinal cord in the rat. I. The lower thoracic and lumbosacral cord. J Comp Neurol 1984; 230:133-41
48. Honoré P, Chapman V, Buritova J, Besson J-M: When is the maximal effect of pre-administered morphine on carrageenin evoked spinal c-fos expression in the rat? Brain Res 1995; 705:91-6
49. Lombard M-C, Besson J-M: Attempts to gauge the relative importance of pre- and postsynaptic effects of morphine on the transmission of noxious messages in the dorsal horn of the rat spinal cord. Pain 1989; 37:335-45
50. Kangra I, Randic M: Outflow of endogenous aspartate and glutamate from the rat spinal dorsal horn in vitro by activation of low-and high-threshold primary afferent fibres. Modulation by opioids. Brain Res 1991; 553:347-52
51. Hori Y, Endo K, Takahashi T: Presynaptic inhibitory action of enkephalin on excitatory transmission in superficial dorsal horn of rat spinal cord. J Physiol 1992; 450:673-85
52. 2 using microdialysis in conscious rats. Br J Pharmacol 1995; 114:1069-75
53. Duggan AW, North RA: Electrophysiology of opioids. Pharmacol Rev 1984; 35:219-81
54. Basbaum AI, Besson J-M: Towards a New Pharmacotherapy of Pain. Dahlem Konferenzen, J Wiley, 1991, p 457
55. Dickenson AH: Where and how do opioids act? Proceedings of the 7th World Congress on Pain. Edited by Gebhart GF, Hammond DL, Jensen TS. Seattle, IASP, 1994, pp 525-53
56. Dickenson AH, Sullivan AF: Electrophysiological studies on the effects of intrathecal morphine on nociceptive neurones in the rat dorsal horn. Pain 1986; 24:211-22
57. Liu H, Wang H, Sheng M, Jan LY Jan YN, Basbaum AI: Evidence for presynaptic N-methyl-D-aspartate autoreceptors in the spinal cord dorsal horn. Proc Natl Acad Sci U S A 1994; 91:8383-7
58. Chery DA, Plummer JL, Gourlay GK, Coates KR, Odgers CL: Ketamine as an adjunct to morphine in the treatment of pain. Pain 1995; 62:119-21